日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered exosomes with Kras(G12D) specific siRNA in pancreatic cancer: a phase I study with immunological correlates.

利用 Kras(G12D) 特异性 siRNA 工程化外泌体治疗胰腺癌:一项具有免疫学相关性的 I 期研究。

Kalluri Valerie S, Smaglo Brandon G, Mahadevan Krishnan K, Kirtley Michelle L, McAndrews Kathleen M, Mendt Mayela, Yang Sujuan, Maldonado Ana S, Sugimoto Hikaru, Salvatierra Maria E, Solis Soto Luisa M, Haymaker Cara, Finch Rick, Gagea Mihai, Fluty Adam C, Ludtke Steven J, Jack Lee J, Jain Abhinav K, Varadhachary Gauri, Shroff Rachna T, Maitra Anirban, Shpall Elizabeth, Pant Shubham, Kalluri Raghu

Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology

关于风湿病学和神经病学领域周围神经系统疾病命名法统一的建议

Noaiseh, Ghaith; Deboo, Anahita; King, Jennifer K; Varadhachary, Arun; Sarka, George; Goodman, Brent P; Hammitt, Katherine M; Frantsve-Hawley, Julie; Fox, Robert; Baker, Matthew C; Danielides, Stamatina; Mandel, Steven; Pavlakis, Pantelis P; Scofield, R Hal; Wallace, Daniel J; Carteron, Nancy; Carsons, Steven

Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders

11h 的药理学特性及临床前评价:一种新型的、可穿透血脑屏障的 PDE4 抑制剂,用于治疗神经系统疾病

Lackovic, Jacob; Dey, Sougata; Ward, Sara Jane; Greig, Nigel H; Tweedie, David; Beiranvand, Nassim; Saini, Uksha; Chatterjee, Dev; Varadhachary, Atul

KRAS (G12D) -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients

利用工程化外泌体进行KRAS(G12D)特异性靶向治疗,可重编程免疫微环境,从而提高胰腺癌患者免疫检查点疗法的疗效。

LeBleu, Valerie S; Smaglo, Brandon G; Mahadevan, Krishnan K; Kirtley, Michelle L; McAndrews, Kathleen M; Mendt, Mayela; Yang, Sujuan; Maldonado, Ana S; Sugimoto, Hikaru; Salvatierra, Maria E; Solis Soto, Luisa M; Finch, Rick; Gagea, Mihai; Fluty, Adam C; Ludtke, Steve J; Lee, J Jack; Jain, Abhinav K; Varadhachary, Gauri; Shroff, Rachna T; Maitra, Anirban; Shpall, Elizabeth; Kalluri, Raghu; Pant, Shubham

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

一项多中心随机对照试验,比较新辅助放化疗单独使用或联合帕博利珠单抗治疗可切除或临界可切除胰腺腺癌患者的疗效

Katz, Matthew H G; Petroni, Gina R; Bauer, Todd; Reilley, Matthew J; Wolpin, Brian M; Stucky, Chee-Chee; Bekaii-Saab, Tanios S; Elias, Rawad; Merchant, Nipun; Dias Costa, Andressa; Lenehan, Patrick; Cardot-Ruffino, Victoire; Rodig, Scott; Pfaff, Kathleen; Dougan, Stephanie K; Nowak, Jonathan Andrew; Varadhachary, Gauri R; Slingluff, Craig L; Rahma, Osama

Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study

基因组分析在原发灶不明癌症中的可行性和价值:来自前瞻性分析研究的真实世界证据

Huey, Ryan W; Shah, Aakash Tushar; Reddi, Honey V; Dasari, Priyadarsini; Topham, James T; Hwang, Hyunsoo; Dhillon, Nishat; Willett, Anneleis; Smaglo, Brandon G; Estrella, Jeannelyn S; Rashid, Asif; Matamoros, Aurelio; Overman, Michael J; Choquette, Linda; Omerza, Greg; Kelly, Kevin; Wang, Xuemei; Loree, Jonathan M; Rueter, Jens; Varadhachary, Gauri R; Raghav, Kanwal

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

帕博利珠单抗治疗原发灶不明晚期癌症(CUP)患者的疗效:一项 II 期非随机临床试验

Raghav, Kanwal P; Stephen, Bettzy; Karp, Daniel D; Piha-Paul, Sarina A; Hong, David S; Jain, Dipti; Chudy Onwugaje, Dilichukwu O; Abonofal, Abdulrahman; Willett, Anneleis F; Overman, Michael; Smaglo, Brandon; Huey, Ryan W; Meric-Bernstam, Funda; Varadhachary, Gauri R; Naing, Aung

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

PIONEER-Panc:一项针对局部胰腺癌新疗法和新兴疗法的II期随机对照试验平台

Douglas, Julia E; Liu, Suyu; Ma, Junsheng; Wolff, Robert A; Pant, Shubham; Maitra, Anirban; Tamm, Eric P; Bhosale, Priya; Katz, Matthew H G; Varadhachary, Gauri R; Koay, Eugene J

Bilateral Painful Hand Seizures: An Atypical Somatotopic Syndrome

双侧手部疼痛性癫痫发作:一种非典型体感综合征

Koleske, Joshua; Amar, Jordan Y; Chou, Chris A; Varadhachary, Arun S

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

PD-L1(阿特珠单抗)和VEGF(贝伐珠单抗)联合阻断治疗晚期恶性腹膜间皮瘤的疗效、安全性和生物标志物分析

Raghav, Kanwal; Liu, Suyu; Overman, Michael J; Willett, Anneleis F; Knafl, Mark; Fu, Szu-Chin; Malpica, Anais; Prasad, Seema; Royal, Richard E; Scally, Christopher P; Mansfield, Paul F; Wistuba, Ignacio I; Futreal, Andrew P; Maru, Dipen M; Solis Soto, Luisa M; Parra Cuentas, Edwin R; Chen, Honglei; Villalobos, Pamela; Verma, Anuj; Mahvash, Armeen; Hwu, Patrick; Cortazar, Patricia; McKenna, Edward; Yun, Cindy; Dervin, Shannon; Schulze, Katja; Darbonne, Walter C; Morani, Ajaykumar C; Kopetz, Scott; Fournier, Keith F; Woodman, Scott E; Yao, James C; Varadhachary, Gauri R; Halperin, Daniel M